SPY412.27-3.80 -0.91%
DIA338.12-3.18 -0.93%
IXIC13,818.41-131.81 -0.94%

Calithera Biosciences Q4 EPS $(0.32), Inline

Calithera Biosciences (NASDAQ:CALA) reported quarterly losses of $(0.32) per share which met the analyst consensus estimate. This is a 17.95 percent increase over losses of $(0.39) per share from the same period last

· 03/16/2021 16:09
Calithera Biosciences (NASDAQ:CALA) reported quarterly losses of $(0.32) per share which met the analyst consensus estimate. This is a 17.95 percent increase over losses of $(0.39) per share from the same period last year.